Loading company…
Wuxi-based biopharmaceutical company developing and marketing medicines for treatment, prevention and biological reagents.
Established in 2002 and based in Wuxi, China, Royal (Wuxi) Bio-pharmaceutical Co., Ltd. develops, manufactures and markets medicines for treatment and prevention, along with biological reagents. In September 2021 the company completed a strategic investment from Jun Yuan Capital. Its site covers more than 100000 square meters, with a total phase I investment of 25 million dollars, and scientists make up 70% of staff. The company has developed a freeze-dried group A and C meningococcal conjugate vaccine for children aged 6 months to 2 years.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in